Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus

Translated title of the contribution: Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus
Original language	Undefined/Unknown
Pages (from-to)	685-697
Number of pages	13
Journal	European Journal of Clinical Microbiology & Infectious Diseases
Volume	20
Publication status	Published - 2001

Cite this

@article{152664bfe77c4425a86c7ed392f3de1f,

title = "Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus",

author = "R. Geisel and F.J. Schmitz and A.C. Fluit and H. Labischinski",

year = "2001",

language = "Undefined/Unknown",

volume = "20",

pages = "685--697",

journal = "European Journal of Clinical Microbiology \& Infectious Diseases",

issn = "0934-9723",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus

AU - Geisel, R.

AU - Schmitz, F.J.

AU - Fluit, A.C.

AU - Labischinski, H.

PY - 2001

Y1 - 2001

M3 - Article

SN - 0934-9723

VL - 20

SP - 685

EP - 697

JO - European Journal of Clinical Microbiology & Infectious Diseases

JF - European Journal of Clinical Microbiology & Infectious Diseases

ER -